Amylyx Pharmaceuticals | 4:持股变动声明-高管 Klee Justin B.
Amylyx Pharmaceuticals | 4:持股变动声明-高管 Cohen Joshua B
Amylyx Pharmaceuticals | 4:持股变动声明-高管 Bedrosian Camille L
Amylyx Pharmaceuticals | 4:持股变动声明-高管 Mazzariello Gina
Amylyx Pharmaceuticals | 4:持股变动声明-高管 Cohen Joshua B
Amylyx Pharmaceuticals | 4:持股变动声明-高管 Cohen Joshua B
Amylyx Pharmaceuticals | 4:持股变动声明-高管 FRATES JAMES M
Amylyx Pharmaceuticals | 4:持股变动声明-董事 Firestone Karen
Amylyx Pharmaceuticals | 4/A:持股变动声明(修正)-高管 FRATES JAMES M
Amylyx Pharmaceuticals | 4:持股变动声明-董事 MILNE GEORGE M JR
Amylyx Pharmaceuticals | SC 13G:超过5%持股股东披露文件-TCG Crossover GP II, LLC(6.8%),TCG Crossover Fund II, L.P.(6.8%)等
Amylyx Pharmaceuticals | 10-Q:2024财年二季报
Amylyx Pharmaceuticals | 8-K:Amylyx 制药公布2024年第二季度财务业绩
Amylyx Pharmaceuticals | 8-K:重大事件
Amylyx Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(3.9%)
Amylyx Pharmaceuticals | 8-K:重大事件
Amylyx Pharmaceuticals | 4:持股变动声明-董事 FONTEYNE PAUL R.
Amylyx Pharmaceuticals | 4:持股变动声明-董事 Firestone Karen
Amylyx Pharmaceuticals | 4:持股变动声明-董事 Zeiher Bernhardt G
Amylyx Pharmaceuticals | 4:持股变动声明-董事 MILNE GEORGE M JR
暂无数据
暂无数据